Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1523052
This article is part of the Research Topic Advanced Therapeutic Strategies in Digestive and Circulatory Health: Nanomedicine and Beyond View all articles

Analysis of Nanomedicine Applications for Inflammatory Bowel Disease: Structural and Temporal Dynamics, Research Hotspots, and Emerging Trends

Provisionally accepted
Hong-Yu Jiang Hong-Yu Jiang 1Bo Shao Bo Shao 1Hong-da Wang Hong-da Wang 1Wen-Qi Zhao Wen-Qi Zhao 2Shao-hua Ren Shao-hua Ren 1Yi-ni Xu Yi-ni Xu 1Tong Liu Tong Liu 1Cheng-lu Sun Cheng-lu Sun 1Yi-yi Xiao Yi-yi Xiao 1Yi-cheng Li Yi-cheng Li 1Qiang Chen Qiang Chen 1Peng-yu Zhao Peng-yu Zhao 1Guang-mei Yang Guang-mei Yang 1Xu Liu Xu Liu 1Yu-fan Ren Yu-fan Ren 1Hao Wang Hao Wang 1,2*
  • 1 Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China
  • 2 Tianjin Key Laboratory of Precise Vascular Reconstruction and Organ Function Repair, Tianjin, China

The final, formatted version of the article will be published soon.

    The application of nanomedicine in inflammatory bowel disease (IBD) has gained significant attention in the recent years. As the field rapidly evolves, analyzing research trends and identifying research hotpots are essential for guiding future advancements, and a comprehensive bibliometric can provide valuable insights.The current research focused on publications from 2001 to 2024, and was sourced from the Web of Science Core Collection (WoSCC). CiteSpace and VOSviewer were employed to visualize authors, institutions, countries, co-cited references, and keywords, thereby mapping the intellectual structure and identifying emerging trends in the field.The analysis covered 1,518 literatures across 447 journals, authored by 9334 researchers from 5,459 institutions and 287 countries/regions. The global publication numbers exhibited an upward trend, particularly in the last decade, with China leading as the top publishing country and the Chinese Academy of Sciences emerging as the foremost institution. Dr. Xiao Bo is the prominent figure in advanced drug delivery systems. This interdisciplinary field, which spans materials science, pharmacy, and medicine, has seen influential publications mainly concentrated on targeted nanoparticles treatment for IBD. Keyword analysis revealed that current research hotspots include drug delivery, immune cell regulation, antioxidant damage, intestinal microbiota homeostasis, and nanovesicles.This study offers a comprehensive overview of global research landscape, emphasizing the rapid growth and increasing complexity of this field. It identifies key research hotspots and trends, including efforts to enhance the precision, efficacy, and safety of nanomedicine applications. Emerging directions are highlighted as crucial for further progress in this evolving area.

    Keywords: Bibliometrics, Nanomedicine, inflammatory bowel disease, Research trends, Emerging frontiers

    Received: 05 Nov 2024; Accepted: 24 Dec 2024.

    Copyright: © 2024 Jiang, Shao, Wang, Zhao, Ren, Xu, Liu, Sun, Xiao, Li, Chen, Zhao, Yang, Liu, Ren and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Hao Wang, Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.